Picture of Vaxart logo

VXRT — Vaxart News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapTurnaround

Vaxart Inc reports results for the quarter ended in September - Earnings Summary

* Vaxart Inc  VXRT.OQ  reported a quarterly adjusted loss
of 23
cents​​ per share for the quarter ended in September. The mean
expectation of four analysts for the quarter was for a loss
of 24 cents per share.
    * Reported revenue was zero​; analysts expected $66.67
thousand. 
    * Vaxart Inc's reported EPS for the quarter was a loss of 23
cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Vaxart Inc shares had fallen by 34.4% this quarter and
lost 77.2% so far this year.
    * The company reported a quarterly loss of $29.31 million.
    * Wall Street's median 12-month price target for Vaxart Inc
is
$7.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.24          -0.23          Beat
 Jun. 30 2022      -0.21          -0.23          Missed
 Mar. 31 2022      -0.16          -0.20          Missed
 Dec. 31 2021      -0.17          -0.17          Met

Recent news on Vaxart

See all news